HomeATOS • NASDAQ
Follow
Atossa Therapeutics Inc
Previous close
$1.83
Day range
$1.83 - $1.91
Year range
$0.59 - $1.94
Market cap
233.69M USD
Avg Volume
1.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.47M | -8.98% |
Net income | -6.23M | 22.24% |
Net profit margin | — | — |
Earnings per share | -0.05 | 16.67% |
EBITDA | -7.46M | 9.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 94.03M | -19.88% |
Total assets | 101.70M | -19.75% |
Total liabilities | 3.44M | 20.08% |
Total equity | 98.25M | — |
Shares outstanding | 125.30M | — |
Price to book | 2.35 | — |
Return on assets | -17.78% | — |
Return on capital | -18.38% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -6.23M | 22.24% |
Cash from operations | -3.88M | 28.23% |
Cash from investing | -1.00K | 99.96% |
Cash from financing | -1.48M | — |
Net change in cash | -5.36M | 34.41% |
Free cash flow | -777.50K | 69.32% |
About
Founded
2008
Headquarters
Website
Employees
11